Incretin-Based Drugs Market Trends 2025: GLP-1 & DPP-4 Inhibitor Developments | Leading Companies - AstraZeneca, Boehringer Ingelheim, Inc., Sanofi, Takeda Pharmaceutical Company Limited, Novartis AG DataM Intelligence unveils its latest report on the "Incretin-Based Drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics
~ Studies show it can be used to heal tendon injuries, tissue injuries, and eye injuries
You might need to adjust your dose based on how your body responds, and a batch of prefilled syringes at the wrong dose is wasted medication
3 The VTE risk reduction was observed across most BMI categories
Others turn to it to ease stress, anxiety, or bad moods